{"DataElement":{"publicId":"7054994","version":"1","preferredName":"Tumor Mass Prostate Histologic Type","preferredDefinition":"The classification of benign, borderline, or malignant neoplasm that affects the prostate gland based on the type of tissue in which a tumor originated.","longName":"6796606v1.0:7055167v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"6796606","version":"1","preferredName":"Tumor Mass Histologic Type","preferredDefinition":"A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells._Refers to the type of tissue in which a tumor originated.","longName":"4976411v1.0:2673286v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"4976411","version":"1","preferredName":"Tumor Mass","preferredDefinition":"A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells.","longName":"C98275","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Mass","conceptCode":"C98275","definition":"A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1DC5FA96-6845-8A34-E050-BB89AD4344BC","latestVersionIndicator":"Yes","beginDate":"2015-08-20","endDate":null,"createdBy":"DAVISJ","dateCreated":"2015-08-20","modifiedBy":"ONEDATA","dateModified":"2015-08-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2673286","version":"1","preferredName":"Histologic Type","preferredDefinition":"Refers to the type of tissue in which a tumor originated.","longName":"C61478","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic Type","conceptCode":"C61478","definition":"Refers to the type of tissue in which a tumor originated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3820C878-7530-31CC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-20","endDate":null,"createdBy":"UMLLOADER_BCR","dateCreated":"2007-08-20","modifiedBy":"ONEDATA","dateModified":"2007-08-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8C3F2573-4FAB-6BB5-E053-F662850AE327","latestVersionIndicator":"Yes","beginDate":"2019-06-26","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-06-26","modifiedBy":"KNABLEJ","dateModified":"2020-02-14","changeDescription":"2/14/20 jk Upd RD to \"Qualified\"; CPTAC released AI. 1/2/20 jk Released per CPTAC SME (Linda) for PRAD Baseline CRF. 7/26/19 jk Updated OC term to Tumor Mass; used on multiple CPTAC CRFs.  6/26/19 jk created for CPTAC Baseline CRFs.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7055167","version":"1","preferredName":"Prostate Tumor Histologic Type","preferredDefinition":"A benign, borderline, or malignant neoplasm that affects the prostate gland.  Representative examples include benign prostate phyllodes tumor, prostatic intraepithelial neoplasia, prostate carcinoma, and prostate sarcoma._Refers to the type of tissue in which a tumor originated._Something distinguishable as an identifiable class based on common qualities.","longName":"7055167v1.0","context":"OCCPR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Prostate Adenocarcinoma, Acinar Type, NOS","valueDescription":"Acinar Prostate Adenocarcinoma","ValueMeaning":{"publicId":"3686425","version":"1","preferredName":"Acinar Prostate Adenocarcinoma","longName":"3686425","preferredDefinition":"An invasive adenocarcinoma of the prostate gland composed of secretory cells.  It is the most common histologic type of prostate adenocarcinoma.  Several morphologic variants exist, including atrophic, pseudohyperplastic, foamy gland, and oncocytic variants.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Acinar Adenocarcinoma","conceptCode":"C5596","definition":"An invasive adenocarcinoma of the prostate gland composed of secretory cells.  It is the most common histologic type of prostate adenocarcinoma.  Several morphologic variants exist, including atrophic, pseudohyperplastic, foamy gland, and oncocytic variants.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C713B1-B72A-DF11-E040-BB89AD436E24","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"COOPERM","dateModified":"2019-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9742CDE2-F8DE-4A6F-E053-F662850A66D3","beginDate":"2019-11-13","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-13","modifiedBy":"ONEDATA","dateModified":"2019-11-13","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other Histologic Type","ValueMeaning":{"publicId":"7331757","version":"1","preferredName":"Other Histologic Type","longName":"7331757","preferredDefinition":"A selected option that indicated an other histologic type.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other Histologic Type","conceptCode":"C159613","definition":"A selected option that indicated an other histologic type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A80C0DF2-F90A-58A8-E053-4EBD850A7EC2","latestVersionIndicator":"Yes","beginDate":"2020-06-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-14","modifiedBy":"ONEDATA","dateModified":"2020-06-14","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/03/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A80C73DE-390A-758F-E053-4EBD850A86BE","beginDate":"2019-11-13","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-14","modifiedBy":"ONEDATA","dateModified":"2020-06-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7055166","version":"1","preferredName":"Prostate Neoplasm Histologic Type Type","preferredDefinition":"A benign, borderline, or malignant neoplasm that affects the prostate gland.  Representative examples include benign prostate phyllodes tumor, prostatic intraepithelial neoplasia, prostate carcinoma, and prostate sarcoma.:Refers to the type of tissue in which a tumor originated.:Something distinguishable as an identifiable class based on common qualities.","longName":"C3343:C61478:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Neoplasm","conceptCode":"C3343","definition":"A benign, borderline, or malignant neoplasm that affects the prostate gland.  Representative examples include benign prostate phyllodes tumor, prostatic intraepithelial neoplasia, prostate carcinoma, and prostate sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Histologic Type","conceptCode":"C61478","definition":"Refers to the type of tissue in which a tumor originated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9742CDE2-F8A2-4A6F-E053-F662850A66D3","latestVersionIndicator":"Yes","beginDate":"2019-11-13","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-13","modifiedBy":"ONEDATA","dateModified":"2019-11-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9742CDE2-F8B3-4A6F-E053-F662850A66D3","latestVersionIndicator":"Yes","beginDate":"2019-11-13","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-13","modifiedBy":"KNABLEJ","dateModified":"2020-06-14","changeDescription":"6/14/20 jk upd Other PV to use CPTAC CUI for \"Other Histologic Type\".   1/2/20 jk Released per CPTAC SME (Linda). 12/27/19 jk added Reg Status. 11/13/19 jk created for CPTAC PRAD baseline CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"5635376","version":"1","longName":"Prostate","context":"OCCPR"},{"publicId":"6779561","version":"1","longName":"PRAD Baseline","context":"OCCPR"},{"publicId":"6779562","version":"1","longName":"PRAD Local Pathology","context":"OCCPR"},{"publicId":"6779563","version":"1","longName":"PRAD Pathology Review","context":"OCCPR"}]}],"AlternateNames":[{"name":"OCCPR","type":"USED_BY","context":"OCCPR"}],"ReferenceDocuments":[{"name":"Histologic Type","type":"Preferred Question Text","description":"Histologic Type","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9741BB2C-AD5E-50EA-E053-F662850AF536","latestVersionIndicator":"Yes","beginDate":"2019-11-13","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-13","modifiedBy":"KNABLEJ","dateModified":"2020-02-13","changeDescription":"2/13/20 jk RS chg to Qualified.   1/2/20 jk Released per CPTAC SME (Linda) for PRAD Baseline CRF. 11/13/19 jk created for CPTAC PRAD baseline CRFs.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}